Healthcare Stocks
Filings and news across 7 industries · newest 12:00 PM ET · How scores work
Fri, Oct 917 events
8BIAFbioAffinity Technologies, Inc.bioAffinity Prices $4M Registered Direct Offering at $6.122 with Warrants7TEVATeva Pharmaceutical Industries LtdTeva Wins FDA Approval for Monthly Schizophrenia Injection7SBFMSunshine Biopharma Inc.Sunshine Biopharma Closes $6M Offering at $0.55, Down from $0.6876 Announced8HUMHumana Inc.Humana Surges 16% to 52-Week High as 95% of Members Land in 4-Star Plans9SXTCChina SXT Pharmaceuticals, Inc.China SXT Finalizes $12M Offering With Zero-Price Warrants That Could Add 72M Shares7MLYSMineralys Therapeutics, Inc.Lorundrostat Hits 46% SBP Control in Resistant Hypertension, Expands OSA Data7ALHCAlignment Healthcare, Inc.Alignment Healthcare Plunges 23% as Key Medicare Plan Loses 4-Star Rating7ATOSAtossa Therapeutics, Inc.Atossa Executes CVR Deal: Shareholders Get 25% of Priority Review Voucher Proceeds7QNCXQuince Therapeutics, Inc.Quince Therapeutics Names Brigette Roberts CEO Amid Restructuring7NTRANatera, Inc.FDA Grants Breakthrough Device Designation to Natera's Multi-Cancer Early Detection Assay8QNCXQuince Therapeutics, Inc.Quince Therapeutics Rebrands as IRulya Therapeutics with New Leadership and $116M Cash Runway Through 20287SPTXSeaport Therapeutics, Inc.GlyphAgo Phase 1 PK Shows 6.8x Bioavailability, 10x Lower Variability8GKOSGLAUKOS CorpiDose TR Beats Cataract Surgery Alone in Phase 4, Cutting IOP by 3.6 mmHg More7IAMIambic TherapeuticsIambic Therapeutics IPO Gets $60M Anchor Interest from ARK and Duquesne7HUMHumana Inc.Humana's 2027 Star Ratings Jump: 95% of MA Members in 4-Star+ Plans7HUMHumana Inc.Humana Exceeds Top Quartile Medicare Advantage Star Ratings Goal for 20277ALMSALUMIS INC.Envudeucitinib Shows Rapid, Durable Relief Across Scalp, Itch, and Quality of Life in Phase 3
Thu, Oct 823 events
8RTSNRetension Pharmaceuticals, Inc.Retension Pharmaceuticals Prices Upsized $45M IPO at $12/Share7TRXBTrexbio, Inc.Trexbio Prices IPO at $14, Raising $116.7M8GENNQGenesis HealthcareGenesis Healthcare Wins Court Approval for $1B Bankruptcy Sale8PHVSPharvaris N.V.Pharvaris' Deucrictibant Phase 3 Data Published in The Lancet, Showing Rapid HAE Attack Resolution8PPCBPropanc Biopharma, Inc.Propanc Biopharma Approves Reverse Stock Split to Preserve Nasdaq Listing7NWBONorthwest Biotherapeutics IncNW Bio Partners with UK NHS Blood and Transplant to Scale DCVax-L Production8FBLGFibroBiologics, Inc.FibroBiologics Sells $1.2M Convertible Debenture at 15% Discount to Peak One8FULCFulcrum Therapeutics, Inc.Fulcrum S-4 Amendment Adds HSR Clearance and Slate Phase 1 Trial Launch to Reverse Merger7NXLNexalin Technology, Inc.Nexalin Registers 5.75M Shares for Alumni Capital Resale, Reveals Exchange Cap Limits $15M Equity Line7TLRYTilray Brands, Inc.Tilray Q1 Loss Widens; Credit Facility Access Restricted by New Covenant Amendment8ALHCAlignment Healthcare, Inc.Alignment Healthcare's Key California Plan Drops to 3.5 Stars in CMS 2027 Ratings8PASGPassage BIO, Inc.Passage Bio Sets Nov 5 Vote on Remix Merger; Net Cash Estimate Rises to $10.9M8BMGLBasel Medical Group LtdBasel Medical Finalizes $7.98M Unit Offering at $1.33 — Zero-Cash Warrants Could Add 6M Shares8PCVXVaxcyte, Inc.Vaxcyte Finalizes $500M Equity Offering at $64/Share Alongside $500M Convertible Notes7LFWDLifeward Ltd.Lifeward CFO Pick Rami Aviram Backs Out Before Start Date9JAGXJaguar Health, Inc.Jaguar Health Seeks Approval for Up to 92.9% Dilution, Reverse Split, and ELOC Floor Price Cut7ALPSAlps Group IncAlps Group Seeks Shareholder Approval for 1-for-5 Reverse Split and Share Capital Increase7TENXTenax Therapeutics, Inc.Tenax Pauses LEVEL-2 Enrollment to Amend Protocol After LEVEL Data7QSIQuantum-Si IncProteus Platform Reaches 19 Amino Acids, Closing In on Full 20-Amino-Acid Detection7GHGuardant Health, Inc.Guardant360 CDx Wins European Approval as Companion Diagnostic for AstraZeneca's ETCAMAH7VREOFVireo Growth Inc.Vireo Growth Secures $60M Real Estate Loan at 8.5% to Own NY and FL Cultivation Facilities8IMCCIM Cannabis Corp.IM Cannabis Registers 2.8M Shares for Resale — 170% Dilution Overhang, CEO Among Sellers8TRAWTraws Pharma, Inc.Traws Pharma Seeks Stockholder Approval for 1-for-8 to 1-for-15 Reverse Split to Regain Nasdaq Compliance
How Wiseek picks and scores these
How Wiseek curates this list
Every item here is a high-importance (score ≥ 7) SEC filing or licensed news event for a healthcare company, sourced from SEC EDGAR and licensed news wires and ranked by Wiseek's 1–10 importance score. The underlying source is linked from each article. See our methodology and editorial policy.